Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab—A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach

Systemic lupus erythematosus (SLE) is a clinically heterogeneous autoimmune disease, and organ manifestations, such as lupus nephritis (LN) or skin disease, may be refractory to standard treatment. Therefore, new agents are required to allow for a more personalized therapeutic approach. Recently, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Plüß, Marlene, Piantoni, Silvia, Wincup, Chris, Korsten, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225134/
https://www.ncbi.nlm.nih.gov/pubmed/35743519
http://dx.doi.org/10.3390/jcm11123449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225134/
https://www.ncbi.nlm.nih.gov/pubmed/35743519
http://dx.doi.org/10.3390/jcm11123449

Ejemplares similares